Cyclin E amplification, over-expression, and relapse-free survival in HER-2-positive primary breast cancer

Prognostic value of cyclin E expression in breast cancer: a meta-analysis

(2013) Sheng Gao et al.   TUMOR BIOLOGY

Survival in patients with metastatic recurrent breast cancer after adjuvant chemotherapy

(2012) Amye J. Tevaarwerk et al.   CANCER

Cyclin E Low-Molecular-Weight Isoform as a Predictor of Breast Cancer in Japanese Women

(2012) Yukiko Tokai et al.   INTERNATIONAL SURGERY

Prognostic Value of Basal Phenotype in HER2-overexpressing Breast Cancer

(2011) Sanjay P. Bagaria et al.   ANNALS OF SURGICAL ONCOLOGY

Low molecular weight cyclin E is specific in breast cancer and is associated with mechanisms of tumor progression

(2011) Hannah Wingate et al.   CELL CYCLE

Management and Outcome of HER2-Positive Early Breast Cancer Treated With or Without Trastuzumab in the Adjuvant Trastuzumab Era

(2011) Carlo Palmieri et al.   Clinical Breast Cancer

Cyclin E amplification/overexpression is a mechanism of trastuzumab resistance in HER2+breast cancer patients

(2011) Maurizio Scaltriti et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A Study to investigate the role of p27 and Cyclin E immunoexpression as a prognostic factor in early breast carcinoma

(2011) Komala Pillay et al.   World Journal of Surgical Oncology

Genome profiling of ERBB2-amplified breast cancers

(2010) Fabrice Sircoulomb et al.   BMC CANCER

Low Molecular Weight Cyclin E Overexpression Shortens Mitosis, Leading to Chromosome Missegregation and Centrosome Amplification

(2010) Rozita Bagheri-Yarmand et al.   CANCER RESEARCH

Molecular profiling of invasive breast cancer by multiplex ligation-dependent probe amplification-based copy number analysis of tumor suppressor and oncogenes

(2010) Cathy B Moelans et al.   MODERN PATHOLOGY

A novel interaction between HER2/neu and cyclin E in breast cancer

(2010) E A Mittendorf et al.   ONCOGENE

Genomic Architecture Characterizes Tumor Progression Paths and Fate in Breast Cancer Patients

(2010) H. G. Russnes et al.   Science Translational Medicine

Even Low-level HER2 Expression May be Associated With Worse Outcome in Node-positive Breast Cancer

(2009) Michael Z. Gilcrease et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Altered Subcellular Localization of Tumor-Specific Cyclin E Isoforms Affects Cyclin-Dependent Kinase 2 Complex Formation and Proteasomal Regulation

(2009) N. A. Delk et al.   CANCER RESEARCH